acute promyelocytic leukemia; target therapy; genetic heterogeneity1. Introduction Heterogeneity in the universe of leukemias is a constant reality. When it comes to acute leukemias, APL is quite distinct because it has a pathognomonic marker, i.e., the translocation between chromosomes 15 and 17,...